Dr. Gong explains the causes of pink eye and discusses treatments.
What causes pink eye is either allergic response to things in the air. It could be bacterial. And it could be viral.
They typical treatment for pink eye, if its allergic there are allergy-drops we can give but allergy-drops will dry out your eyes so we give also samples of some lubricating drops that you can buy over-the-counter.
If it is bacterial then we can give an antibiotic drop to take care of that and also if it’s viral we give them lubricating drops.
We do tell our patients not to share towels. Change your towels out every day. Make sure you always wash your hands before you touch your eye if you are wearing contacts. Otherwise we prefer you not touch your eye.
Continue use the lubricating drops and any other treatment that’s prescribed by your doctor.
Sometimes we even give warm compresses if the lids are still crusting shut. That will loosen up the debris so that you can clean that off with baby shampoo or any kind of antibacterial soap.
About Dr. Aleta Gong, O.D., F.A.A.O., F.C.O.V.D.:
Dr. Aleta Gong, O.D., F.A.A.O., F.C.O.V.D., is a graduate of the University of California San Diego and the Southern California College of Optometry. She is a Board Certified Fellow of the American Academy of Optometry and of the College of Optometrists in Vision Development. She has had extensive training at several hospitals and has been trained in specialty contacts, ocular disease, and vision therapy.
She is an active member of the American Optometric Association, and is past president of the Arizona Optometric Association. She also has been one of two state directors for the Special Olympics Opening Eyes Program since 2001.
Presently, she is the state liaison for the nurse’s vision screening program for Arizona. She was a state board proctor for the Arizona licensing board from 1993 to 2001. Dr. Gong has been chosen to be a C.O.P.E. reviewer for national lectures. Dr. Gong also started the InfantSEE® program for Arizona.
Add a CommentComments
There are no comments yet. Be the first one and get the conversation started!